SPONSORED CONTENT: LONZA - Smart Innovation through Hybrid and 505(b)(2) Regulatory Pathways
At this Virtual Innovation Day event, Lonza will be joined by experts from Camargo, J2Fpharma, IMA Active Solid Dose Solutions and University of Bonn.
The 505(b)(2) regulatory pathway can help pharmaceutical companies alleviate some of the cost and time associated with the traditional full NDA, as well as eliminating the need for most nonclinical studies. Join our panel of industry experts for a deep dive into case studies and actionable insights for navigating pharmaceutical regulation.
Attend this Virtual Innovation Day for:
- Technical solutions to address the challenges linked to multiple product dosing
- Key consideration in the US 505(b)(2) and EU Hybrid (or alternative) application pathways
- Capsule-based solutions for faster pharmaceutical development
To register for this free virtual event, click here.